NCT04505137 A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04503733 A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension Status UNKNOWN Phase PHASE1
NCT04489251 Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension Status UNKNOWN Phase N/A
NCT04483115 Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT04451850 HRV as a Marker of Treatment Response in PAH Arterial Hypertension Status COMPLETED Phase N/A
NCT04435782 A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging Status TERMINATED Phase PHASE4
NCT04416750 Positioning Imatinib for Pulmonary Arterial Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04316143 Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat) Status COMPLETED Phase PHASE2
NCT04309838 Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension Status UNKNOWN Phase N/A
NCT04282434 DNA Methylation Dynamics Underlying Arterial Remodeling in PAH Patients: CLEOPAHTRA Clinical Trial Status COMPLETED Phase N/A
NCT04280523 TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH Status WITHDRAWN Phase N/A
NCT04278404 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) Status RECRUITING Phase N/A
NCT04273945 Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04266197 Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study Status COMPLETED Phase PHASE2
NCT04254289 Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension Status WITHDRAWN Phase NA
NCT04241497 Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism Status UNKNOWN Phase NA
NCT04207593 The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia Status COMPLETED Phase PHASE2